Related Experiment Video
Updated: Feb 7, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Comprehensive molecular profiling of the B7 family in gastrointestinal cancer
Qijie Zhao1, Fuyan Hu2, Zhangang Xiao1
1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Objectives:
B7 family has been identified as co-stimulatory or co-inhibitory molecules on T-cell response and plays an important role in tumour mortality and malignancy. In this study, the expression pattern of B7 family in gastrointestinal (GI) cancer was examined. Its upstream regulating mechanism, downstream targets and association with clinical parameters were also studied.
Materials And Methods:
The expression level of B7 members was analysed by FIREHOUSE. The gene mutation, DNA methylation, association with clinical parameters and downstream network of B7 members were analysed in cBioportal. The mutation frequency was analysed by Catalogue of Somatic Mutations in Cancer (COSMIC) analysis. The phylogenetic tree was constructed in MEGA7. The interaction protein domain analysis was performed by Pfam 31.0.
Results:
Differential expression of B7 family molecules was detected in different kinds of GI cancer. High-frequency gene alteration was found in tumour samples. There was negative correlation of promoter methylation and mRNA expression of B7 family members in tumour samples, suggesting the epigenetic basis of B7 family gene deregulation in GI cancer. The overexpression of B7-H1 in pancreatic cancer, B7-H5 in oesophageal cancer and B7-H6 in liver cancer were significantly associated with worse overall survival. Finally, by network analysis, we identified some potential interacting proteins for B7-1/2 and B7-H1/DC.
Conclusions:
Overall, our study suggested that B7 member deregulation was strongly involved in GI cancer tumorigenesis.
Insights
Deregulation of B7 family molecules is implicated in gastrointestinal (GI) cancer. Specific B7 members like B7-H1, B7-H5, and B7-H6 correlate with poor survival in GI cancers, indicating their role in tumorigenesis.
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- The B7 family comprises co-stimulatory/co-inhibitory molecules crucial for T-cell responses.
- These molecules play a significant role in tumor mortality and malignancy.
Purpose of the Study:
- To investigate the expression patterns of B7 family members in gastrointestinal (GI) cancers.
- To explore the upstream regulatory mechanisms, downstream targets, and clinical associations of B7 family members in GI cancers.
Main Methods:
- Analysis of B7 member expression using FIREHOUSE.
- Utilized cBioportal for gene mutation, DNA methylation, and clinical parameter association studies.
- Employed COSMIC for mutation frequency analysis, MEGA7 for phylogenetic trees, and Pfam 31.0 for protein domain analysis.
Main Results:
- Differential expression of B7 family molecules observed across various GI cancers.
- High-frequency gene alterations and a negative correlation between promoter methylation and mRNA expression suggest epigenetic deregulation.
- Overexpression of B7-H1 (pancreatic), B7-H5 (esophageal), and B7-H6 (liver) cancers associated with worse survival.
Conclusions:
- B7 member deregulation is significantly involved in the tumorigenesis of GI cancers.
- Identified potential interacting proteins for B7-1/2 and B7-H1/DC through network analysis.
More Related Videos
Related Concept Videos
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Family Therapy
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:

